特定于腺素A2A受体的F标记PET标记剂:设计,合成和生物评估
Tingyu Yang1, Wei Zheng2, Xuebo Cheng2
1School of Pharmaceutical Science, Capital Medical University, Beijing 100069, China.
ACS chemical neuroscience
|March 8, 2024
概括
合成了新型A2AR对手,其中[18F]BIBD-399显示出高亲和力和特定的大脑吸收. 这种标志物显示出在神经成像研究中监测A2AR变化和区分病变的潜力.
科学领域:
- 药用化学 医学化学
- 放射化学 放射化学是指辐射化学.
- 神经科学是一个神经科学.
背景情况:
- 氨酸A2A受体 (A2AR) 是神经系统疾病的关键目标.
- 在A2AR的正子发射断层扫描 (PET) 成像中,开发特定的放射标志物至关重要.
研究的目的:
- 设计和合成新型的A2AR抗剂和辐射追踪剂.
- 评估它们的结合亲和力,特异性,药理动力学特性和成像能力.
主要方法:
- 新型化合物的化学合成.
- 在体外受体结合测试.
- [18F]标记的标记物的放射合成.
- 在动物模型中进行体内生物分布研究和PET成像.
- 在体外自发放射和分子对接.
主要成果:
- 化合物3,12c和BIBD-399对A2AR具有很高的亲和力.
- [F]3和[F]BIBD-399已经成功合成.
- [18F]BIBD-399显示了特定的大脑吸收,快速平衡,以及高的A2AR结合特异性.
- [18F]BIBD-399在tMCAo模型中有效地区分了心脏病发作和非心脏病发作的大脑区域.
结论:
- [F]BIBD-399具有有利的药理动力学特性和高A2AR特异性.
- 它显示出作为PET成像剂的潜力,用于监测A2AR表达和检测大脑病变.
- 需要对[18F]BIBD-399进行进一步的临床研究.
相关概念视频
Positron Emission Tomography
4.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.2K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
114
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
114
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.0K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.0K
![Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F55537.jpg&w=3840&q=50)

![Microwave-assisted One-pot Synthesis of N-succinimidyl-4-[18F]fluorobenzoate [18F]SFB](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F2755.jpg&w=3840&q=50)